Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Tauzin claims PhRMA resignation not tied to any political fallout on reform efforts

This article was originally published in Scrip

Executive Summary

Billy Tauzin stunned many in the industry when he recently announced that he would resign in June as president and chief lobbyist of the US pharmaceutical industry body, PhRMA (, February 13th, 2010). Close-knit Washington, DC was abuzz with talk that the departure seemed all too sudden and had the look and feel of an ouster at the hands of pharma CEOs. But the 66-year-old told The Washington Post his decision to step down was more a matter of personal timing.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts